Qu Z

No ORCID on file · 6 papers in corpus · active 2021-2026

Study types

  • article 2
  • other 1

Condition tags

  • endometriosis 2
  • dysmenorrhea 1
  • infertility 1
  • adenomyosis 1
2026
Advanced science (Weinheim, Baden-Wurttemberg, Germany) ·doi:10.1002/advs.75094

Blood-based liquid biopsies hold transformative potential for non-invasive cancer management, but current approaches relying on rare circulating tumor components limit their broad clinical utility. Platelets, abundant in blood and mediating…

article 2023
Frontiers in pharmacology ·doi:10.3389/fphar.2023.1089004

Introduction: Dahuang-Taoren (DT) is a classic combination of botanical drugs applied to treat pain-related diseases in ancient China. Today, DT is frequently applied for dysmenorrhea of adenomyosis (AM) in the clinic. Growing evidence indi…

article 2023
Alternative therapies in health and medicine

AIM: To observe the effect of warming menstruation and analgesic herbal soup (WMAS) on the pathway of programmed cell death protein 1 and its ligand 1 PD-1/PD-L1 in rats with endometriosis model. METHODS: A total of 90 mature female Wistar…

2022
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2022/3675689

ObjectiveThis study aims to explore the effect of the prescription for Zhujingqiaoyun receptivity in patients with infertility.MethodsThis project is a prospective randomized controlled clinical study, including infertility diagnostic crite…

other 2022
Endocrine ·doi:10.1007/s12020-021-02867-y

PURPOSE: Adulthood and childhood obesity are both associated with reproductive diseases and gynecological cancers in females. However, the causal factors associated with these observations have yet to be identified. Mendelian randomization …

2021
·doi:10.21203/rs.3.rs-390994/v1

Abstract Purpose: Adulthood and childhood obesity are associated with female reproductive endocrinology and gynecological cancers. However, the causality of such association is yet to be identified. Independent of inverse bias and confound…